Search Results - Joshua E. Allen

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Correction: First-In-Class Small Molecule ONC201 Induces DR5 and Cell Death in Tumor but Not Normal Cells to Provide a Wide Therapeutic Index as an Anti-Cancer Agent. by Joshua E Allen, Roslyn N Crowder, Wafik S El-Deiry

    Published in PLoS ONE (2016-01-01)
    Get full text
    Article


  2. 2

    Correction: Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway by Joshua E Allen, Gabriel Krigsfeld, Luv Patel, Patrick A Mayes, David T Dicker, Gen Sheng Wu, Wafik S El-Deiry

    Published in Molecular Cancer (2024-10-01)
    Get full text
    Article


  3. 3

    A novel dopamine receptor D2 antagonist (ONC206) potentiates the effects of olaparib in endometrial cancer by Sarah E. Paraghamian, Jianqing Qiu, Gabrielle M. Hawkins, Ziyi Zhao, Wenchuan Sun, Yali Fan, Xin Zhang, Hongyan Suo, Tianran Hao, Varun Vijay Prabhu, Joshua E. Allen, Chunxiao Zhou, Victoria Bae-Jump

    Published in Cancer Biology & Therapy (2023-12-01)
    Get full text
    Article


  4. 4

    ONC213: a novel strategy to resensitize resistant AML cells to venetoclax through induction of mitochondrial stress by Jenna L. Carter, Yongwei Su, Eman T. Al-Antary, Jianlei Zhao, Xinan Qiao, Guan Wang, Holly Edwards, Lisa Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Steven A. Buck, Maik Hüttemann, Joshua E. Allen, Varun V. Prabhu, Jay Yang, Jeffrey W. Taub, Yubin Ge

    Get full text
    Article


Search Tools: